Novo Nordisk af Kurt Jacobsen

Spar op til

182 kr.

50/100
Gennemsnitlig bog
ifølge 1 anmelder

Novo NordiskEnglish versionaf Kurt Jacobsen

Today Novo Nordisk is Denmark’s largest industrial enterprise and one of the most highly valued companies in the world. The company is a global leader in pharmaceuticals for the treatment of diabetes, hemophilia disorders, and obesity, and it has positioned itself at the forefront with regard to social responsibility, environmental protection, and sustainability.
For the first time, this book tells the whole story of a basement business that was built into a global pharmaceutical company. It all began in 1922, when insulin came to Denmark and inspired the establishment of two companies, Nordisk Insulin Laboratorium and Novo Terapeutisk Laboratorium. After many years of fierce rivalry, the two companies merged in 1989 in order to be able to survive in global competition. Soon after, years of merger negotiations brought Novo Nordisk to the brink of moving out of Denmark.
The story of Novo Nordisk is a story of groundbreaking research and big bets but also of setbacks and crises. A story of strong leaders and personalities but also of family struggles and company infighting. The book is based on full and unhindered access to the company’s archives.
50/100
Gennemsnitlig bog
ifølge 1 anmelder
De bedste priser:

Én boganmeldelseLæs mere

Vi er stødt på 1 anmeldelse af bogen "Novo Nordisk" i de 503 aviser, blogs og andre medier, vi følger. Find citater, links og korte uddrag herunder.

50/100
WA
Middelmådig anmeldelse i Weekendavisen
anmeldt af Nikolaj Arve Henningsen 17-03-2023
En lidt uforløst bog, mangelfuld til tider og jævnt kedelig

Insulinchok

Novo Nordisk. Med to tunge bøger på bare fire år om Danmarks mest værdifulde virksomhed er der en vis risiko for overdosering. Men der er brug for en tredje. [Kort uddrag]